Skip to content
10-Q

Quarterly Report

ENTASIS THERAPEUTICS HOLDINGS INC.

0001558370-21-005938

← back to feed
Filed
May 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Apr 30, 2021 37.31M sh
Cash And Equivalents Q1 2021 · Mar 31, 2021 $44.94M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $53.25M
Current Liabilities Q1 2021 · Mar 31, 2021 $8.03M
Current Liabilities Q1 2021 · Dec 31, 2020 $8.57M
Total Liabilities Q1 2021 · Mar 31, 2021 $8.57M
Total Liabilities Q1 2021 · Dec 31, 2020 $9.27M
Current Assets Q1 2021 · Mar 31, 2021 $51.55M
Current Assets Q1 2021 · Dec 31, 2020 $60.13M
Total Assets Q1 2021 · Mar 31, 2021 $52.83M
Total Assets Q1 2021 · Dec 31, 2020 $61.56M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$13.57M
Stockholders Equity Q1 2021 · Mar 31, 2020 $27.7M
Stockholders Equity Q1 2021 · Dec 31, 2019 $42.16M
Sga Expense Q1 2021 · Mar 31, 2020 $3.78M
Rd Expense Q1 2021 · Mar 31, 2020 $11.62M
Net Income Q1 2021 · Mar 31, 2020 −$15.27M
Operating Income Q1 2021 · Mar 31, 2020 −$15.4M